1. Introduction
===============

Recently, an increasing number of patients with critical limb ischemia (CLI) are undergoing medical care at clinical practice sites. Improving the outcome of treatment for these patients is an important and urgent issue. Since 2013, the Japanese Society for Vascular Surgery (JSVS) has initiated the project of a nationwide CLI registration and tracking database to obtain CLI epidemiological data that can be shared among the medical staff. The background of CLI limbs, contents of treatment, early outcome, and long-term outcome until five years after surgery, including non-surgical limbs, are registered in this database. The database was named JAPAN Critical Limb Ischemia Database (JCLIMB) and established on the National Clinical Database (NCD). The JCLIMB project's primary objective is to clarify the current status of CLI treatment performed by vascular surgeons in Japan and inform physicians at practice sites, thus improving the quality of medical care. The initial registration data, and their tracking data one month after registration in 2013--2016, have already been published.^[@R1]--[@R4])^ This article reports the basic data registered in 2017.

2. JCLIMB
=========

Registration details, including the definition of CLI, have already been described in the 2013 annual report.^[@R1])^ CLI to be registered was defined according to TASC II^[@R5])^: chronic ischemic rest pain, ulcers, or gangrene attributable to objectively proven arterial occlusive disease. CLI diagnosis should be confirmed by ankle pressure (AP) below 50 mmHg or by toe pressure (TP) below 30 mmHg in limbs with rest pain, and done by AP below 70 mmHg or by TP below 50 mmHg in limbs with ulcer or gangrene.

The same limb can be registered in JCLIMB only once within a five-year tracking period. When the registered limb is treated at different times or at different institutions, such data should be added only to the tracking items of each limb in JCLIMB, avoiding registration overlap. However, details of the procedure are registered each time in NCD apart from the registration in JCLIMB. On the other hand, the patient with bilateral CLI can be registered twice for each limb. Based on NCD regulations, fixing JCLIMB data is done as follows:

Initial registration data: Early April in the following year, tracking data early after treatment (one month)/six months after treatment: end of December in the following year, tracking data one year after treatment: end of December after two years.

Tracking data two years after treatment: end of December after three years

Tracking data three years after treatment: end of December after four years

Tracking data four years after treatment: end of December after five years

Tracking data five years after treatment: end of December after six years

As a general rule, the timing of tracking data registration is accepted within a ±2-month range until 12 months after treatment, and within a ±3-month range thereafter. Although the day for tracking data fixing is specified, it is made flexible because, in some limbs, follow-up data might be revealed later.

It is very difficult to require facilities participating in NCD to register CLI data since a great number of registration items in JCLIMB would put too much burden on them. Thus, facilities wishing to participate were recruited. In total, 84 facilities, which registered CLI limbs in 2017 at the time of compiling in September 2019, are listed in the appendix.

Since JCLIMB is positioned as a registry study on NCD, patient consent to participate in the study, and the ethical review of the study at the time of participation in NCD were adopted.

3. Comments on the Aggregated Data in 2017
==========================================

The initial registration data in 2017 were fixed in early April 2018, and the tracking data early after treatment (one month) were fixed on December 31, 2018. At that time, 1137 limbs, those of 760 males (67%) and 377 females (33%), were registered in 84 facilities. All data and extracted data on arteriosclerosis obliterans (ASO) were collected according to the registered items. Since ASO accounted for 98% of all limbs, the overall and ASO data showed similar tendencies. In the comments, ASO data were presented in parentheses. In addition, because the Society for Vascular Surgery (SVS)'s WIfI classification was reported in 2014 ([**Tables 1-1-1**](#table1-1-1){ref-type="table"}[](#table1-1-2){ref-type="table"} to [**1-1-3**](#table1-1-3){ref-type="table"}),^[@R6])^ JCLIMB made several changes and additions to the registered items, making the WIfI classification possible since 2015 ([**Tables 1-2-1**](#table1-2-1){ref-type="table"}[](#table1-2-2){ref-type="table"} to [**1-2-3**](#table1-2-3){ref-type="table"}). The total figure was not always consistent, mostly due to missing values, and an explanation for each inconsistency was added.

###### Table 1-1 SVS WIfI classification original^6）^ Table 1-1-1 Wound

  Grade                                                                                                                                          Ulcer                                                                                                            Gangrene
  ---------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------
  0                                                                                                                                              No ulcer No gangrene                                                                                             No gangrene
  Clinical description: ischemic rest pain (requires typical symptoms, ischemia grade 3); no wound.                                                                                                                                                               
  1                                                                                                                                              Small, shallow ulcer(s) on distal leg or foot; no exposed bone, unless limited to distal phalanx                 No gangrene
  Clinical description: minor tissue loss. Salvageable with simple digital amputation (1 or 2 digits) or skin coverage.                                                                                                                                           
  2                                                                                                                                              Deeper ulcer with exposed bone, joint or tendon; generally not involving the heel;                               Gangrenous changes limited to digits
  Gangrenous changes limited to digits                                                                                                                                                                                                                            
  shallow heel ulcer, without calcaneal involvement                                                                                                                                                                                                               
  Clinical description: major tissue loss salvageable with multiple (3) digital amputations or standard TMA±skin coverage.                                                                                                                                        
  3                                                                                                                                              Extensive, deep ulcer involving forefoot and/or midfoot; deep, full thickness heel ulcer±calcaneal involvement   Extensive gangrene involving forefoot and/or midfoot; full thickness heel necrosis 6 calcaneal involvement
  Clinical description: extensive tissue loss salvageable only with a complex foot reconstruction or nontraditional TMA (Chopart or Lisfranc);                                                                                                                    
  flap coverage or complex wound management needed for large soft tissue defect                                                                                                                                                                                   

TMA: transmetatarsal amputation

###### Table 1-1-2 Ischemia

  Grade   ABI          AP (mmHg)   TP, TcPO~2~ (mmHg)
  ------- ------------ ----------- --------------------
  0       ≥0.80        \>100       ≥60
  1       0.60--0.79   70--100     40--59
  2       0.40--0.59   50--70      30--39
  3       ≤0.39        \<50        \<30

ABI: ankle brachial (pressure) index, PVR: pulse volume recording, SPP: skin perfusion pressure, TP: toe pressure, TcPO~2~: transcutaneous oximetry Patients with diabetes should have TP measurements. If arterial calcification precludes reliable ABI or TP measurements, ischemia should be documented by TcPO~2~, SPP, PVR. If TP and ABI measurements result or in different grades, TP will be the primary determinant of ischemia grade. Flat or minimally pulsatile forefoot PVR=grade 3.

###### Table 1-1-3 Foot infection

  Grade                                                                                                                                                          Clinical manifestation of infection                                                                                                                                                                                                                          IDSA/PEDIS Infection severity\*
  -------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------
  0                                                                                                                                                              No symptoms or signs of infection                                                                                                                                                                                                                            Uninfected
  1                                                                                                                                                              Infection present, as defined by the presence of at least 2 of the following items:                                                                                                                                                                          Mild
  ·Local swelling or induration                                                                                                                                                                                                                                                                                                                                                                                               
  ·Erythema \>0.5 to 2 cm around the ulcer                                                                                                                                                                                                                                                                                                                                                                                    
  ·Local tenderness or pain                                                                                                                                                                                                                                                                                                                                                                                                   
  ·Local warmth                                                                                                                                                                                                                                                                                                                                                                                                               
  ·Purulent discharge (thick, opaque to white, or sanguineous secretion)                                                                                                                                                                                                                                                                                                                                                      
  Local infection involving only the skin and the subcutaneous tissue (without involvement of deeper tissues and without systemic signs as described below).                                                                                                                                                                                                                                                                  
  Exclude other causes of an inflammatory response of the skin (e.g., trauma, gout, acute Charcot neuro-osteoarthropathy, fracture, thrombosis, venous stasis)                                                                                                                                                                                                                                                                
  2                                                                                                                                                              Local infection (as described above) with erythema \>2 cm, or involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis, septic arthritis, fasciitis), and no systemic inflammatory response signs (as described below)   Moderate
  3                                                                                                                                                              Local infection (as described above) with the signs of SIRS, as manifested by two or more of the following:                                                                                                                                                  Severe
  ·Temperature \>38°C or \<36°C                                                                                                                                                                                                                                                                                                                                                                                               
  ·Heart rate \>90 beats/min                                                                                                                                                                                                                                                                                                                                                                                                  
  ·Respiratory rate \>20 breaths/min or PaCO~2~ \<32 mmHg                                                                                                                                                                                                                                                                                                                                                                     
  ·White blood cell count \>12,000 or \<4,000 cu/mm or 10% immature (band) forms                                                                                                                                                                                                                                                                                                                                              

\*SVS adaptation of Infectious Diseases Society of America (IDSA) and International Working Group on the Diabetic Foot (IWGDF) perfusion, extent/size, PACO~2~: Partial pressure of arterial carbon dioxide, SIRS: systemic inflammatory response syndrome An ischemia may complicate and increase the severity of any infection. Systemic infection may sometimes manifest with other clinical findings, such as hypo-tension, confusion, vomiting, or evidence of metabolic disturbances, such as acidosis, severe hyperglycemia, new-onset azotemia.

###### Table 1-2 SVS WIfI classification: Correlation of WIfI and items in JCLIMB Table 1-2-1 Wound

  Grade     Rutherford classification                Ulcer     Sites of gangrene                                   
  --------- ---------------------------------------- --------- --------------------------------------------------- ---------------------------------
  0         Class 4                                            No ulcer                                            No gangrene
  1         Class 5, 6                               I         Any portion                                         No gangrene
  II, III   Limited to digits                                                                                      
  2         Class 5, 6                               I         Heel                                                Limited to digits
  II, III   Foot: distal metatarsal excluding heel                                                                 
  3         Class 5, 6                               II, III   Foot: proximal metatarsal, heel, ankle, lower leg   Extensive proximal to fore foot

###### Table 1-2-2 Ischemia

  Grade   SPP: (mmHg; calculating from the formula\*)
  ------- ---------------------------------------------
  0       \>55
  1       42--55
  2       35--41
  3       \<35

\*SPP=0.6853XTP+14.48 SPP: skin perfusion pressure, TP: toe pressure

###### Table 1-2-3 Foot infection

  Grade                                                                                                                                                                                                                   Local infection; foot   Systemic infection (SIRS)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ---------------------------
  0                                                                                                                                                                                                                       (−)                     (−)
  1                                                                                                                                                                                                                       (+)                     (−)
  Involving only the skin and the subcutaneous tissue (Erythema around the ulcer; 0.5--2 cm)                                                                                                                                                      
  2                                                                                                                                                                                                                       (+)                     (−)
  Involving only the skin and the subcutaneous tissue (Erythema around the ulcer; \>2 cm), or involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis,septic arthritis, fasciitis)                           
  3                                                                                                                                                                                                                       (+)                     (+)

(1) Pretreatment patients' background
-------------------------------------

Pretreatment patients' background is shown in [**Tables 2-1**](#table2-1){ref-type="table"}[](#table2-2){ref-type="table"}[](#table2-3){ref-type="table"}[](#table2-4){ref-type="table"}[](#table2-5){ref-type="table"} to [**2-6**](#table2-6){ref-type="table"}. Good blood pressure control was defined as below 140/90 mmHg, without diabetes and renal failure, or below 130/80 mmHg with these diseases. Diabetes control was considered good when hemoglobin A1c was below 7.0% (national glycohemoglobin standardization program \[NGSP\] value). Dyslipidemia control was considered good when low-density lipoprotein was below 100 and 80 mg/dL in the absence and presence of other arteriosclerotic diseases, respectively. The presence of heart failure was judged clinically. The patient was regarded as having heart failure based on a past history of admission due to heart failure, clinical symptoms of heart failure, a diagnosis of heart failure was confirmed by echocardiography, or reduced cardiac function on echocardiography even with no clinical heart failure symptoms. Renal dysfunction was graded following the new chronic kidney disease severity classification of the "Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012"^[@R7])^: Renal dysfunction was absent when the estimated glomerular filtration rate (eGFR) (mL/min/1.73 m^2^) was 60 or higher, and it was graded as G3a, G3b, G4, and G5 when eGFR was 45--59, 30--44, 15--29, and below 15, respectively. eGFR below 15 in hemodialysis patients was graded as G5D.

The causes of the arterial occlusion of the limb were ASO in 1114 (98%) limbs, thromboangiitis obliterans (TAO) in 5, vasculitis (Takayasu's arteritis, collagen disease, Behçet's disease, and fibromuscular dysplasia excluding TAO) in 9, and others in 9. Patients comorbidities consisted of diabetes in 62% (63%) of the limbs, hypertension in 76% (77%), dyslipidemia in 36% (36%), ischemic heart disease in 39% (40%), cerebrovascular disease in 20% (20%), dialysis for renal failure in 42% (42%), past medical history of malignant neoplasm or that being treated in 9% (9%), and arterial occlusive lesions in the contralateral limb in 78% (79%).

###### Table 2-1 Patients' back ground 1

  a\. Total                                                                                                                                                             
  -------------- -------- ------- ------------ -------------- --------------------- ------ ------ -------- --- --- ------ -------- ------ ------- ------ ------- ------ --------
  Rutherford 4   221      151     70           106            115                   21.6   216    0        2   3   74.9   (9.6)    ---    ---     69.0   (4.2)   65.3   (14.4)
  Rutherford 5   744      501     243          365            379                   21.1   727    5        7   5   74.5   (10.2)   48.8   (7.6)   57.6   (9.5)   71.2   (8.7)
  Rutherford 6   172      108     64           83             89                    20.4   171    0        0   1   72.9   (9.9)    ---    ---     ---    ---     84.0   ---
  Total          1137     760     377          554            583                   21.1   1114   5        9   9   74.3   (10.0)   48.8   (7.6)   60.1   (9.8)   70.7   (11.1)
  b\. ASO                                                                                                                                                               
                 n        Sex     Laterality   BMI (Median)   Age at registration                                                                                       
  Male           Female   Right   Left         Mean (±SD)                                                                                                               
  Rutherford 4   216      148     68           104            112                   21.6   74.9   (9.6)                                                                 
  Rutherford 5   727      491     236          359            368                   21.1   74.5   (10.2)                                                                
  Rutherford 6   171      107     64           83             88                    20.4   72.9   (9.9)                                                                 
  Total          1114     746     368          546            568                   21.1   74.3   (10.0)                                                                

Vasculitis: Takayasu's arteritis, collagen disease, Behcet disease, FMD etc.， excluding TAO Others: others (including debranch bypasses for TEVAR or EVAR) ASO: arteriosclerosis obliterans, TAO: thromboangiitis obliterans, FMD: fibromuscular dysplasia, BM: body mass index, TEVAR: thoracic endovascular aortic/aneurysm repair, EVAR: endovascular aortic/aneurysm repair

###### Table 2-2 Patients' back ground 2

  a\. Total                                                                                                                                      
  -------------- ------------ ------------------ -------------- ----------------- --------- ----- ----- ----- ----- ----- ----- ---- ----- ----- -----
  Rutherford 4   99           93                 29             15                72        35    41    151   29    132   79    10   75    110   36
  Rutherford 5   276          367                101            57                237       174   193   485   66    482   225   37   314   328   102
  Rutherford 6   56           80                 36             15                58        43    39    102   31    114   51    7    75    77    20
  Total          431          540                166            87                367       252   273   738   126   728   355   54   464   515   158
  b\. ASO                                                                                                                                        
                 Diabetes     Diabetes therapy   Hypertension   Dyslipidemia      Smoking                                                        
  (−)            (+)          Diet therapy       Medication     Insulin therapy   (−)       (+)   (−)   (+)   (−)   (+)                          
  Management     Management   Management         Ex-smoker      Current smoker                                                                   
  Good           Poor         Good               Poor           Good              Poor                                                           
  Rutherford 4   94           93                 29             15                72        35    39    149   28    128   79    9    73    107   36
  Rutherford 5   263          363                101            54                237       173   182   480   65    468   222   37   308   321   98
  Rutherford 6   55           80                 36             15                58        43    39    101   31    113   51    7    75    77    19
  Total          412          536                166            84                367       251   260   730   124   709   352   53   456   505   153

Blood pressure management good: diabetes or renal failure (−) \<140/90 mmHg (+) \<130/80 mmHg. Diabetes management good: HbA1c\<7.0% (NGSP). Dyslipidemia management good: other sclerotic lesions (−) LDL\<100 mg/DL, (+) LDL\<80 mg/DL. HbA1c: hemoglobin A1c, LDL: low-density lipoprotein, NGSP: national glycohemoglobin standardization program

###### Table 2-3 Patients' back ground 3

  a\. Total                                                                                                                                                   
  ------------------- ------------------------ --------------- ------------------------- ------------------- ----- ----- ----- ----- ----- ---- ---- ---- --- -----
  Rutherford 4        142                      23              33                        23                  192   29    187   34    108   17   16   10   1   69
  Rutherford 5        458                      73              127                       86                  636   108   594   150   259   61   68   25   6   325
  Rutherford 6        88                       26              32                        26                  133   39    129   43    54    18   15   3    2   80
  Total               688                      122             192                       135                 961   176   910   227   421   96   99   38   9   474
  b\. ASO                                                                                                                                                     
                      Ischemic heart disease   Heart failure   Cerebrovascular disease   Renal dysfunction                                                    
  (−)                 (+)                      (−)             (+)                       (−)                 (+)   (−)   (+)                                  
  Medical treatment   PCI                      CABG            G3a                       G3b                 G4    G5    G5D                                  
  Rutherford 4        137                      23              33                        23                  187   29    182   34    106   15   15   10   1   69
  Rutherford 5        444                      72              125                       86                  619   108   577   150   246   59   67   25   6   324
  Rutherford 6        88                       25              32                        26                  133   38    128   43    53    18   15   3    2   80
  Total               669                      120             190                       135                 939   175   887   227   405   92   97   38   9   473

PCI: percutaneous coronary intervention, CABG: coronary arterial bypass grafting Heart failure (+): history of admission due to heart failure, clinical symptoms due to heart failure confirmed by ultrasound examination, apparently decreased cardiac function by ultrasound examination without clinical symptoms. Renal dysfunction: (−) (60≦), G3a (45--59), G3b (30--44), G4 (15--29), G5 (\<15), G5D (\<15 with hemodialysis). New CKD risk stratification by eGFR (ml/min/1.73 m^2^) in "Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012." eGFR: estimated glomerular filtration rate, CKD: chronic kidney disease

###### Table 2-4 Patients' back ground 4

  a\. Total                                                                                                                                                                                     
  ------------------- -------------------- ----------------------------- ----------- ------ --------- ------------------------ ------- -------- -------- --------- ---------- -------- --- ---- ----
  Rutherford 4        197                  15                            7           2      1         1                        2       2        2        9         3          1        0   1    5
  Rutherford 5        674                  51                            17          2      2         3                        11      9        6        14        4          1        0   14   13
  Rutherford 6        162                  8                             2           0      0         0                        1       0        2        4         0          0        0   0    3
  Total               1033                 74                            26          4      3         4                        14      11       10       27        7          2        0   15   21
  b\. ASO                                                                                                                                                                                       
                      Malignant neoplasm   Sites of malignant neoplasm                                                                                                                          
  (−)                 (+)                  Head and neck                 Esophagus   Lung   Stomach   Hepatobiliary pancreas   Colon   Breast   Uterus   Ovarium   Prostate   Others            
  History of cancer   Under treatment\*    Unknown                                                                                                                                              
  Rutherford 4        193                  14                            7           2      1         1                        2       2        2        8         3          1        0   1    5
  Rutherford 5        658                  51                            16          2      2         3                        11      9        5        14        4          1        0   14   13
  Rutherford 6        161                  8                             2           0      0         0                        1       0        2        4         0          0        0   0    3
  Total               1012                 73                            25          4      3         4                        14      11       9        26        7          2        0   15   21

\*Including palliative therapy or recurrence.

###### Table 2-5 Patients' back ground 5

  a\. Total                                                                                                                                                                                                                                                           
  -------------- -------------------------------------- -------------------------------------- ---------------- -------- ----- -------- ----- -------- --------------------- ---------------------------- ------------------ -------- ------ ------ --- ---- --- ---- ----
  Rutherford 4   62                                     51                                     20               37       5     0        46    176      0.81                  26                           0.62               77       35.0   200    0   8    1   11   1
  Rutherford 5   156                                    207                                    53               23       143   7        155   525      0.77                  65                           0.35               334      37.0   684    8   13   2   19   18
  Rutherford 6   30                                     45                                     10               3        15    30       39    83       0.82                  10                           0.37               53       42.0   162    1   6    0   3    0
  Total          248                                    303                                    83               63       163   37       240   784      0.78                  101                          0.39               464      37.0   1046   9   27   3   33   19
  b\. ASO                                                                                                                                                                                                                                                             
                 Contralateral limb occlusive lesions   Vascular lesions excluding occlusion                                                                                                                                                                          
  (−)            (+)                                                                                                                                                                                                                                                  
  Asymptomatic   Intermittent claudication              CLI                                    Post-treatment   ABI      TBI   SPP      (−)   TAA      AAA (including IAA)   Peripheral artery aneurysm   Carotid stenosis   Others                                   
  R4             R5                                     R6                                     n                Median   n     Median   n     Median                                                                                                                  
  Rutherford 4   61                                     48                                     20               36       5     0        46    171      0.81                  26                           0.62               75       35.0   196    0   7    1   11   1
  Rutherford 5   146                                    205                                    53               23       139   7        154   510      0.76                  65                           0.35               326      37.0   669    7   13   1   19   18
  Rutherford 6   30                                     45                                     10               2        15    30       39    83       0.82                  10                           0.37               53       42.0   162    1   5    0   3    0
  Total          237                                    298                                    83               61       159   37       239   764      0.78                  101                          0.39               454      37.0   1027   8   25   2   33   19

ABI: ankle brachial (pressure) index, TBI: toe brachial (pressure) index, SPP: skin perfusion pressure, CLI: critical limb ischemia, TAA: thracic aortic aneurysm, AAA: abdominal aortic aneurysm, IAA: iliac artery aneurysm

###### Table 2-6 Patients' back ground 6

  a\. Total                                                                                                                    
  ----------------------- ----------------------------- ---------------------------- -------- ------ -------- ------- -------- -----
  Rutherford 4            6                             162.9                        6        59.0   6        118.2   6        0.4
  Rutherford 5            22                            168.1                        22       42.4   22       96.2    22       0.3
  Rutherford 6            4                             158.1                        4        83.3   4        179.2   4        0.5
  Total                   32                            163.6                        32       47.2   32       100.0   32       0.3
  b\. ASO                                                                                                                      
                          Fatty acid                                                                                           
  Arachidonic acid (AA)   Eicosapentaenoic acid (EPA)   Docosahexaenoic acid (DHA)   EPA/AA                                    
  n                       Median                        n                            Median   n      Median   n       Median   
  Rutherford 4            6                             162.9                        6        59.0   6        118.2   6        0.4
  Rutherford 5            21                            164.6                        21       40.8   21       95.2    21       0.2
  Rutherford 6            4                             158.1                        4        83.3   4        179.2   4        0.5
  Total                   31                            162.6                        31       44.0   31       99.8    31       0.3

(2) Conditions of limb ischemia
-------------------------------

Limb ischemia pretreatment conditions are shown in [**Tables 3-1**](#table3-1){ref-type="table"}[](#table3-2){ref-type="table"}[](#table3-3){ref-type="table"}[](#table3-4){ref-type="table"}[](#table3-5){ref-type="table"} to [**3-6**](#table3-6){ref-type="table"}. Regarding the walking function (Taylor classification),^[@R8])^ patients who could walk outdoors or indoors independently, including with a cane, were regarded as "ambulatory," and those unable to walk but able to stand on their own legs during transfer from the bed to a wheel chair were designated as "ambulatory/ homebound."

###### Table 3 Pretreatment condition Table 3-1 Pretreatment condition 1

  a\. Total                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  --------------------------- --------------------------------------------- ---------------- ---------------- ------------------------- -------------------------------------------- ------ ------- ----------- ------------------------- ---- ----- ----- -------- ------------------------- --------------------------- ------ ------- ----------- ------------------------- ----- ------------------------- --------------------------- ------ ------- ----------- ----
  Rutherford 4                168                                           29               24                                                                                                                                                                                                                                                                                                                                                                       
  Rutherford 5                442                                           169              133              580                       78                                           25     57      17          13                        67   472   139   133      377                       47                          12     30      8           5                         336   605                       66                          15     37      10          11
  Rutherford 6                55                                            54               63               60                        37                                           41     54      18          16                        29   45    49    78       60                        44                          29     41      12          13                        44    31                        38                          24     48      12          19
  Total                       665                                           252              220              640                       115                                          66     111     35          29                        96   517   188   211      437                       91                          41     71      20          18                        380   636                       104                         39     85      22          30
  b\. ASO                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                              Ambulatory function                           Sites of ulcer   Depth of ulcer   Sites of gangrene         Main sites of ulcer/gangrene to be treated                                                                                                                                                                                                                                                                                    
  (Taylor's classification)   (University of Texas classification: grade)                                                                                                                                                                                                                                                                                                                                                                                             
  Ambulatory                  Ambulatory/homebound                          Nonambulatory    Digits           Foot: distal metatarsal   Foot: proximal metatarsal                    Heel   Ankle   Lower leg   Only gangrene w/o ulcer   I    II    III   Digits   Foot: distal metatarsal   Foot: proximal metatarsal   Heel   Ankle   Lower leg   Only ulcer w/o gangrene   Toe   Foot: distal metatarsal   Foot: proximal metatarsal   Heel   Ankle   Lower leg   
  Rutherford 4                164                                           28               24                                                                                                                                                                                                                                                                                                                                                                       
  Rutherford 5                428                                           166              133              565                       77                                           25     57      17          12                        67   458   139   130      368                       46                          12     30      8           5                         329   590                       65                          15     37      10          10
  Rutherford 6                55                                            53               63               59                        36                                           40     53      17          15                        29   44    49    78       59                        43                          28     40      11          12                        44    31                        38                          24     48      12          18
  Total                       647                                           247              220              624                       113                                          65     110     34          27                        96   502   188   208      427                       89                          40     70      19          17                        373   621                       103                         39     85      22          28

University of Texas classification: grade (I: superficial, not involving tendon, capsule, or bone, II: penetrating to tendon/capsule, III: penetrating to bone or joint)

###### Table 3-2 Pretreatment condition 2

  a\. Total                                                                                                                                                                                                                                                                                                   
  -------------- ------------------ ------------ -------------- ----------------- -------- ------- -------- ------ -------------- -------------- ---------- ------ -------- ------ -------- ------------ ---------------------------------------------- ------------------- ------------ ----- ---- ---- ---- ------
  Rutherford 4   218                3            213            6,670             209      0.39    183      3.60   213            1.13           121        0.57   14       0.50   94       20.00        13                                             66.0                204          13    4    0    2    219
  Rutherford 5   722                22           734            7,100             717      1.07    682      3.40   734            1.50           460        0.65   30       0.24   460      23.00        29                                             35.0                506          167   26   45   13   731
  Rutherford 6   152                20           168            9,115             167      3.74    155      2.90   169            1.50           75         0.67   6        0.17   75       24.00        6                                              26.0                75           31    20   46   19   153
  Total          1092               45           1115           7,200             1093     1.08    1020     3.40   1116           1.36           656        0.64   50       0.32   629      22.00        48                                             39.0                785          211   50   91   34   1103
  b\. ASO                                                                                                                                                                                                                                                                                                     
                 Temperature ≧38°   Blood test   Hemodynamics   Infection\*^1)^                                                                                                                                                                                                                               
  (−)            (+)                WBC          CRP            Alb               Cr       ABI     TBI      SPP    Toe pressure   Local (foot)   Systemic                                                                                                                                                     
  n              Median             n            Median         n                 Median   n       Median   n      Median         n              Median     n      Median   n      Median   Uninfected   Skin or subcutaneous tissue (erythema)\*^2)^   Deep tissue\*^3)^   SIRS\*^4)^                        
  ≦2.0 cm        \>2.0 cm           (+)          (−)                                                                                                                                                                                                                                                          
  Rutherford 4   213                3            208            6,685             204      0.4     178      3.7    208            1.17           117        0.57   14       0.50   90       20.00        13                                             66.0                199          13    4    0    2    214
  Rutherford 5   705                22           717            7,100             700      1.055   666      3.4    717            1.60           446        0.64   30       0.24   448      23.00        29                                             35.0                493          164   26   44   13   714
  Rutherford 6   152                19           167            9,100             166      3.765   154      2.85   168            1.56           75         0.67   6        0.17   75       24.00        6                                              26.0                74           31    20   46   19   152
  Total          1070               44           1092           7,200             1070     1.075   998      3.4    1093           1.41           638        0.63   50       0.32   613      22.00        48                                             39.0                766          208   50   90   34   1080

WBC: white blood cell, CRP: C reactive protein, Alb: albumin, Cr: creatinine, ABI: ankle brachial (pressure) index, TBI: toe brachial (pressure) index, SPP: skin perfusion pressure, SIRS: systemic inflammatory response syndrome \*^1)^ Presence of infection is defined by the presence of at least 2 of the following items: ①Local swelling or induration, ②Erythema \>0.5 to ≦2 cm around the ulcer, ③Local tenderness or pain, ④Local warmth, ⑤Purulent discharge (thick, opaque to white, or sanguineous secretion). \*^2)^ Local infection at skin and subcutaneous tissue was classified by the spreading of erythema (≦2.0 cm or \>2 cm) around the ulcer/gangrene. \*^3)^ Local infection involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis, septic arthritis, fasciitis). \*^4)^ The signs of SIRS are manifested by two or more of the following: ①Temperature \>38 or \<36°C, ②Heart rate \>90 beats/min, ③Respiratory rate \>20 breaths/min or PaCO~2~\<32 mmHg, ④White blood cell count \>12,000 or \<4000 cu/mm or 10% immature (band) forms.

###### Table 3-3 Pretreatment condition 3

  a\. Total                                                                                                                                                                                                                 
  -------------- -------------------- -------------------- ----------------------------------- ---------------------------------------- ---------------- ----- ---- ---- ---- ----------- --- ----- ----- ----- ----------- -----
  Rutherford 4   134                  118                  20                                  57                                       159              91    11   9    7    25          2   11    32    40    88          16
  Rutherford 5   528                  323                  28                                  151                                      469              452   42   27   23   48          6   85    94    105   263         126
  Rutherford 6   123                  66                   12                                  33                                       99               130   11   5    2    14          0   22    24    26    54          27
  Total          785                  507                  60                                  241                                      727              673   64   41   32   87          8   118   150   171   405         169
  b\. ASO                                                                                                                                                                                                                   
                 Diagnostic imaging   Sites of occlusion   TASC II classification aortoiliac   TASC II classification femoropopliteal                                                                                       
  IADSA          CTA                  Others               Aortoiliac                          Femoropop                                Lower leg/foot   A     B    C    D    No lesion   A   B     C     D     No lesion   
  Rutherford 4   131                  114                  20                                  55                                       156              88    11   9    7    23          2   10    32    39    86          15
  Rutherford 5   515                  316                  28                                  150                                      461              442   42   27   23   47          6   84    94    104   256         120
  Rutherford 6   122                  66                   12                                  33                                       98               129   11   5    2    14          0   22    24    26    53          27
  Total          768                  496                  60                                  238                                      715              659   64   41   32   84          8   116   150   169   395         162

IADSA: intra-arterial digital subtraction angiography, CTA: computed tomography angiography

###### Table 3-4 Pretreatment condition 4

  a\. Total                                                                                                                                                                                                           
  ---------------- ----------------- ------------------------------- ----------------------------- --------------------- ------------------- --------------------- -------- ---- -------- ----- -------- --- -------- ---
  Rutherford 4     114               1.5                             113                           2                     115                 6                     114      13   113      3     113      3   109      3
  Rutherford 5     440               1                               441                           1                     448                 3                     448      4    443      3     447      2   440      3
  Rutherford 6     100               1                               100                           1                     103                 3                     103      4    104      3     106      2   105      3
  Total            654               1                               654                           1                     666                 4                     665      5    660      3     666      2   654      3
  b\. ASO                                                                                                                                                                                                             
                   Bollinger Score                                                                                                                                                                                    
  Common femoral   Deep femoral      Superficial femoral: proximal   Superficial femoral: distal   Popliteal: proximal   Popliteal: distal   Tibioperoneal trunk                                                      
  n                Median            n                               Median                        n                     Median              n                     Median   n    Median   n     Median   n   Median   
  Rutherford 4     113               2                               112                           2                     114                 6                     113      13   112      3.5   112      3   108      3
  Rutherford 5     430               1                               431                           1                     438                 3                     438      5    433      3     437      2   430      3
  Rutherford 6     100               1                               100                           1                     103                 3                     103      4    104      3     106      2   105      3
  Total            643               1                               643                           1                     655                 4                     654      5    649      3     655      2   643      3

###### Table 3-5 Pretreatment condition 5

  a\. Total                                                                                                                                                                                                     
  ---------------------------- -------------------------- --------------------------- ------------------------- -------------------- ------------------ ------ -------- ---- -------- --- -------- --- -------- -----
  Rutherford 4                 110                        9                           109                       6                    111                13     108      12   110      5   108      6   91       5
  Rutherford 5                 439                        13                          437                       13                   440                13     431      13   438      6   429      6   360      9
  Rutherford 6                 106                        13                          101                       13                   106                13     100      13   105      5   100      5   82       13
  Total                        655                        13                          647                       13                   657                13     639      13   653      5   637      5   533      6
  b\. ASO                                                                                                                                                                                                       
                               Bollinger Score                                                                                                                                                                  
  Posterior tibial: proximal   Posterior tibial: distal   Anterior tibial: proximal   Anterior tibial: distal   Peroneal: proximal   Peroneal: distal   Foot                                                    
  n                            Median                     n                           Median                    n                    Median             n      Median   n    Median   n   Median   n   Median   
  Rutherford 4                 109                        8                           108                       6                    110                13     107      12   109      5   107      6   90       4.5
  Rutherford 5                 429                        13                          427                       13                   430                13     421      13   428      5   419      5   351      8
  Rutherford 6                 106                        13                          101                       13                   106                13     100      13   105      5   100      5   82       13
  Total                        644                        13                          636                       13                   646                13     628      13   642      5   626      5   523      6

###### Table 3-6 SVS WIfI classification

  a\. Total                                                                                                                 
  -------------- ------- ---------- ---------------- ------- ---- ----- ----- ----- ----- ----- ----- ---- ---- ----- ----- -----
  Rutherford 4   221     0          0                0       14   29    28    90    204   13    4     0    40   112   9     0
  Rutherford 5   0       278        369              97      63   84    71    389   506   163   67    8    52   64    206   285
  Rutherford 6   0       17         29               126     11   17    12    67    75    29    49    19   0    2     19    86
  Total          221     295        398              223     88   130   111   546   785   205   120   27   92   178   234   371
  b\. ASO                                                                                                                   
                 Wound   Ischemia   Foot infection   Stage                                                                  
  0              1       2          3                0       1    2     3     0     1     2     3     1    2    3     4     
  Rutherford 4   216     0          0                0       14   28    28    86    199   13    4     0    39   108   9     0
  Rutherford 5   0       271        360              96      61   83    69    379   493   160   66    8    50   62    204   276
  Rutherford 6   0       17         29               125     11   17    12    67    74    29    49    19   0    2     19    86
  Total          216     288        389              221     86   128   109   532   766   202   119   27   89   172   232   362

Regarding the state of local tissue defect (Texas University Classification),^[@R9])^ the most severe lesion, the main treatment target, was evaluated. Skin perfusion pressure (SPP) was measured on the foot (base of the toe, dorsum of the foot, or sole) and a lower value was adopted. To perform WIfI classification, the sites of ulcer and gangrene were registered separately. Although SPP is widely used as an objective index for evaluating ischemia in Japan, ischemic grading criteria using SPP is not shown in WIfI classification, in which TP is given top priority. Therefore, in JCLIMB, the SPP value was converted to TP using the conversion equation SPP=0.6853 TP+14.48 from the correlation data of SPP and TP reported in Japan,^[@R10])^ and applied for WIfI ischemic grading ([**Table 1-2-2**](#table1-2-2){ref-type="table"}).

The lesion was considered infected when it showed two or more of the following findings: local swelling or induration, erythema \>0.5 cm around the ulcer, local tenderness or pain, local warmth, and purulent discharge (thick, opaque to white, or sanguineous secretion). In addition, local infections involving only the skin and the subcutaneous tissue, and those involving structures deeper than the skin and subcutaneous tissues, were registered separately. Local infections involving only the skin and the subcutaneous tissue were differentiated based on the size of the erythema around the ulcer, ≦ 2 or \>2 cm.

Systemic inflammatory response syndrome (SIRS), indicating systemic infection, was manifested by two or more of the following signs: temperature \>38°C or \<36°C, heart rate \>90 beats/min, respiratory rate \>20 breaths/min or PaCO~2~ \<32 mmHg, white blood cell count \>12,000 or \<4,000 cu/mm or 10% immature (band) forms. The arteries in the ankle joint region were classified as foot arteries.

In pretreatment, 58% (58%) of the patients were ambulatory, 22% (22%) were ambulatory/homebound, and 19% (20%) were non-ambulatory. On the Rutherford classification (R),^[@R11])^ limbs with categories R4, R5, and R6 accounted for 19% (19%), 66% (65%), and 15% (15%) of the limbs, respectively. The median ankle brachial index (ABI), the toe brachial index (TBI), and the SPP of the measured limbs were 0.64 (0.63), 0.32 (0.32), and 22 mmHg (22 mmHg), respectively. The occlusive legion was located in the aortoiliac artery in 21% (21%) of the limbs, in the femoropopliteal artery in 64% (64%) of the limbs, and in the crural or foot artery in 59% (59%) of the limbs. The multiple occlusive lesions were located in the aortoiliac artery and the femoropopliteal artery in 13% (13%) of limbs, in the aortoiliac artery and the crural or foot artery in 6% (6%), in the femoropopliteal artery and the crural or foot artery in 30% (31%), and in the aortoiliac artery and the femoropopliteal artery and the crural or foot artery in 5% (5%).

We were able to apply the WIfI classification with sufficient data to 875 limbs (855 limbs). On the WIfI classification, limbs with the stages 1, 2, 3, and 4 accounted for 11% (10%), 20% (20%), 27% (27%), and 42% (42%) of the limbs, respectively.

The problems and considerations on these spreadsheets are described below. In [**Table 3-3**](#table3-3){ref-type="table"}, the total number of limbs in TASC II classification differed compared to the number in each column of the site of occlusion. In the "aortoiliac" lesion, a decreased number of that in TASC II classification may have been due to input omission. In the "femoropopliteal" lesion, an increased number of that in TASC II may have been due to including the crural lesions.

In [**Table 3-6**](#table3-6){ref-type="table"}, there was some dissociation between the R and Wound grades. This may be because of the R grade's obscure definition. For example, extensive gangrene involving the forefoot is classified in R5 and W3, while a shallow ulcer without exposure of the distal leg bone is classified in R6 and W1.

In [**Table 3-6**](#table3-6){ref-type="table"}, 88 limbs (86 limbs) were registered as Ischemic grade 0 in WIfI classification. By definition, a limb with Ischemic grade 0 has a TP of 60 mmHg or more (SPP 56 mmHg or more in JCLIMB) or AP higher than 100 mmHg, or if arterial calcification precludes reliable AP or TP measurements, TcPO~2~ 60 mmHg or more ([**Table 1-1-2**](#table1-1-2){ref-type="table"}). There should be no limb with Ischemic grade 0 since CLI registered in JCLIMB is defined according to TASC II. The limbs might be clinically judged to be CLI irrespective of the objective ischemic index, although details are unknown.

In [**Table 3-6**](#table3-6){ref-type="table"}, there were 17 limbs (17 limbs) in which infection was confirmed in R4 limbs, despite the absence of a local wound by definition of R4. This may occur because tissue loss is not always requisite for fI grade.

In [**Table 3-6**](#table3-6){ref-type="table"}, because ischemic grade data were registered in only 875 limbs (855 limbs) among 1137 limbs (1114 limbs), WIfI classification could be implemented for these 875 limbs (855 limbs). In the remaining 262 limbs (259 limbs), the data on TBI, SPP, or ABI in these limbs were registered as unmeasurable or unmeasured. The limbs clinically judged to be CLI could be registered without their objective ischemic index.

(3) Treatment
-------------

[**Tables 4-1**](#table4-1){ref-type="table"}[](#table4-2){ref-type="table"}[](#table4-3){ref-type="table"}[](#table4-4){ref-type="table"}[](#table4-5){ref-type="table"} to [**4-6**](#table4-6){ref-type="table"} show the CLI treatment data. Revascularizations of the affected limbs were performed in 95% (96%) of the registered limbs, and primary major amputations were performed in 2.3% (2.3%) of the registered limbs. Among the surgical reconstruction procedures, distal bypass accounted for 45% (44%). Endovascular treatment (EVT), including EVT alone and hybrid treatment with surgical reconstruction, accounted for 56% (57%) of the total revascularization procedures. EVT applied to the crural or foot artery accounted for 36% (36%) of the total EVT.

###### Table 4 Treatment Table 4-1 Treatment 1

  a\. Total                                                                                                                                                                                                                                                                                                       
  ------------------------- -------------------- ------------------------- ------------------ ---------------------- ------------- ------------------ -------- ----- ------------ ------------------ ------ ------------ --------------------------------- --------------------- --------- ----- ----- ----- ---- ----
  Rutherford 4              90                   1                         203                2                      0             0                  0        0     0            0                  0      0            0                                 0                     0         0     158   42    7    14
  Rutherford 5              259                  0                         719                8                      1             0                  0        0     17           3                  0      0            1                                 2                     0         3     569   98    34   40
  Rutherford 6              60                   0                         160                16                     1             0                  0        0     0            1                  0      0            4                                 4                     0         1     144   15    5    7
  Total                     409                  1                         1082               26                     2             0                  0        0     17           4                  0      0            5                                 6                     0         4     871   155   46   61
  b\. ASO                                                                                                                                                                                                                                                                                                         
                            Treatment            Angiogenic therapy        Amputation         Reoperation                                                                                                                                                                                                         
  Pharmacological therapy   Angiogenic therapy   Arterial reconstruction   Major amputation   Lumber sympathectomy   Bone marrow   Peripheral blood   Others   Toe   Metatarsal   Chopart·Lisfranc   Syme   Below knee   Above knee·knee disarticulation   Hip disarticulation   Unknown   (−)   (+)              
  :1X                       2X                   3X≦                                                                                                                                                                                                                                                              
  Rutherford 4              88                   1                         201                2                      0             0                  0        0     0            0                  0      0            0                                 0                     0         0     155   40    7    14
  Rutherford 5              252                  0                         708                8                      1             0                  0        0     17           3                  0      0            1                                 2                     0         3     556   96    34   38
  Rutherford 6              60                   0                         159                16                     1             0                  0        0     0            1                  0      0            4                                 4                     0         1     143   15    5    7
  Total                     400                  1                         1068               26                     2             0                  0        0     17           4                  0      0            5                                 6                     0         4     854   151   46   59

###### Table 4-2 Treatment 2

  a\. Total                                                                                                                                                                                                                                                                                              
  -------------- ------------------------------- --------------- ---------------------------- -------------------------- --------------------- ----------------------- ------------------- ------------------ ----------------- ------------------------- ------------- ------------------- -------- --- -----
  Rutherford 4   1                               0               3                            23                         23                    22                      13                  3                  5                 11                        1             2                   27       0   103
  Rutherford 5   0                               1               10                           55                         40                    87                      130                 5                  6                 15                        4             2                   79       0   403
  Rutherford 6   0                               0               2                            9                          10                    18                      23                  0                  3                 6                         1             0                   10       0   104
  Total          1                               1               15                           87                         73                    127                     166                 8                  14                32                        6             4                   116      0   610
  b\. ASO                                                                                                                                                                                                                                                                                                
                 Bypass                          TEA             EVT                                                                                                                                                                                                                                     
  Aorta-aorta    Aorta (with suprarenal clamp)   Aorta-femoral   Femoral-proximal popliteal   Femoral-distal popliteal   Femoral-crural/foot   Popliteal-crural/foot   Anatomical others   Axillary-femoral   Femoral-femoral   Extra-anatomical others   Aorta/iliac   Fomoral/popliteal   Others       
  Rutherford 4   1                               0               3                            23                         22                    22                      12                  3                  5                 10                        1             2                   27       0   103
  Rutherford 5   0                               1               10                           55                         39                    84                      123                 4                  6                 15                        4             2                   78       0   401
  Rutherford 6   0                               0               2                            9                          10                    17                      23                  0                  3                 6                         1             0                   10       0   104
  Total          1                               1               15                           87                         71                    123                     158                 7                  14                31                        6             4                   115      0   608

TEA: thromboendarterectomy, EVT: endovascular treatment/therapy

###### Table 4-3 Treatment 3

  a\. Total                                                                                                                                                                      
  -------------- ------------------- --------------------- ------------ -------------- ------- ------ -------- ----- --------- -------------- ---------- --------- ------ ------ ----
  Rutherford 4   35                  63                    34           3              8       36     67       1     20        14             28         19        11     63     4
  Rutherford 5   110                 228                   199          2              29      63     275      4     30        39             120        106       19     256    19
  Rutherford 6   23                  59                    62           1              3       11     49       0     10        9              22         19        3      46     3
  Total          168                 350                   295          6              40      110    391      5     60        62             170        144       33     365    26
  b\. ASO                                                                                                                                                                        
                 EVT                 Vascular prosthesis   Vein usage   Vein quality                                                                                             
  Aorta/iliac    Femoral/popliteal   Tibioperoneal/foot    Others       Polyester      ePTFE   Vein   Others   (−)   In-situ   Non-reversed   Reversed   Spliced   Good   Poor   
  Rutherford 4   35                  63                    34           3              8       34     63       1     20        14             28         16        9      60     3
  Rutherford 5   109                 227                   198          2              28      63     263      4     29        39             114        101       18     244    19
  Rutherford 6   23                  59                    62           1              3       11     48       0     10        9              21         19        3      45     3
  Total          167                 349                   294          6              39      108    374      5     59        62             163        136       30     349    25

###### Table 4-4 Treatment 4

  a\. Total                                                                                                                                                                                                                                                                                                                                                      
  ---------------------- -------------------- -------------------------------------------- ------------------------------------------ -------------------- ------------------ -------- -------- -------- ------ --------------------- ------------------ ----------------- ---------- ------------------ ----------------- ---------- ---------------- --------- ----
  Rutherford 4           0                    14                                           2                                          8                    6                  4        2        1        17     19                    2                  12                1          2                  7                 2          1                9         0
  Rutherford 5           5                    46                                           6                                          36                   25                 89       5        7        79     137                   6                  34                31         10                 22                20         5                78        15
  Rutherford 6           0                    6                                            3                                          6                    4                  18       3        1        13     28                    0                  7                 4          2                  8                 2          0                16        3
  Total                  5                    66                                           11                                         50                   35                 111      10       9        109    184                   8                  53                36         14                 37                24         6                103       18
  b\. ASO                                                                                                                                                                                                                                                                                                                                                        
                         Distal bypass                                                                                                                                                                                                                                                                                                                           
  Proximal anastomosis   Distal anastomosis   Distal anastomosis: sites of crural artery   Distal anastomosis: sites of foot artery                                                                                                                                                                                                                              
  External iliac         Common femoral       Deep femoral                                 Superficial femoral                        Proximal popliteal   Distal popliteal   Crural   Others   Crural   Foot   Tibioperoneal trunk   Posterior tibial   Anterior tibial   Peroneal   Posterior tibial   Anterior tibial   Peroneal   Dorsalis pedis   Plantar   
  Rutherford 4           0                    14                                           2                                          8                    6                  3        2        1        17     18                    2                  12                1          2                  6                 2          1                9         0
  Rutherford 5           5                    44                                           6                                          35                   25                 82       5        7        75     131                   5                  32                31         9                  20                20         5                77        12
  Rutherford 6           0                    6                                            3                                          6                    4                  18       2        1        13     27                    0                  7                 4          2                  7                 2          0                16        3
  Total                  5                    64                                           11                                         49                   35                 103      9        9        105    176                   7                  51                36         13                 33                24         6                102       15

###### Table 4-5 Treatment 5

  a\. Total                                                                            
  -------------- ------------------------- --------------- --------- -------- -------- ----
  Rutherford 4   137                       17              13        16       21       15
  Rutherford 5   414                       36              44        40       41       21
  Rutherford 6   99                        10              12        10       11       2
  Total          650                       63              69        66       73       38
  b\. ASO                                                                              
                 Pharmacological therapy                                               
  Antiplatelet   VKA                       Prostaglandin   Heparin   Statin   Others   
  Rutherford 4   135                       16              13        16       20       14
  Rutherford 5   403                       34              44        39       41       18
  Rutherford 6   99                        10              12        10       11       2
  Total          637                       60              69        65       72       34

Antiplatelet: aspirin, cilostazol, Beraprost, sarpogrelate, ticlopidine, clopidogrel, ethyl icosapentate.

###### Table 4-6 Treatment 6

  a\. Total                                                                                                      
  ----------- ----------------------------------- --------------------------------- ---------------------------- ------------------------------
  Polyester   7                                   5                                 2                            4
  ePTFE       52                                  20                                6                            9
  Vein        34                                  49                                118                          156
  Artery      1                                   3                                 6                            5
  Others      3                                   0                                 1                            0
  (−)         3                                   1                                 0                            1
  Total       100                                 78                                133                          175
  b\. ASO                                                                                                        
              Femoral-proximal popliteal bypass   Femoral-distal popliteal bypass   Femoral-crural/foot bypass   Popliteal-crural/foot bypass
  Polyester   7                                   5                                 2                            4
  ePTFE       51                                  20                                6                            8
  Vein        33                                  47                                114                          147
  Artery      1                                   3                                 6                            5
  Others      3                                   0                                 1                            0
  (−)         3                                   1                                 0                            1
  Total       98                                  76                                129                          165

The problems and considerations on these spreadsheets are described below. In [**Table 4-1**](#table4-1){ref-type="table"}, the sum of the number of cells in treatment is larger than the number of registered limbs, 1137 (1114), because more than one treatment method can be selected. In [**Table 4-1**](#table4-1){ref-type="table"}, angiogenic therapy was performed in one limb. However, there was no record in detail of angiogenic therapy because of "unused." The discrepancy in the number of major amputation to the number of detail of amputation was caused by the same reason. In the column of "vein usage" of [**Table 4-3**](#table4-3){ref-type="table"}, how the autologous veins were used were described when they were selected as vascular conduits. The sum of the number in the column of vein usage; "in-situ," "non-reversed," "reversed," and "spliced" is larger than the sum of the number in the column of vein in vascular prosthesis. It could be because of selecting multiple vein usage for arterial reconstruction in a limb. Two veins were used in 16 limbs and three veins were used in one limb. Vascular prosthesis (−) included an endarterectomy without a patch angioplasty. In [**Table 4-4**](#table4-4){ref-type="table"}, the sum of the number of proximal anastomosis is not equal to the sum of the number of distal anastomosis. This was because multiple arteries could be selected in each anastomosis. The sum of the number of distal (crural/foot) bypass in [**Table 4-2**](#table4-2){ref-type="table"} is not equal to the sum of the number of distal anastomosis in [**Table 4-4**](#table4-4){ref-type="table"}. This was because multiple anastomosis sites could be selected in distal bypass in [**Table 4-4**](#table4-4){ref-type="table"}, though either femoral-crural/foot or popliteal-crural/foot was selected in bypass in [**Table 4-2**](#table4-2){ref-type="table"}. In R-5, the sum of the number of crural/foot bypass 217 (207) in [**Table 4-2**](#table4-2){ref-type="table"} is larger than that of distal anastomosis in [**Table 4-4**](#table4-4){ref-type="table"}. This was because both femoral-crural/foot and popliteal-crural/foot were recorded in [**Table 4-2**](#table4-2){ref-type="table"} and only "foot" of distal anastomosis in [**Table 4-4**](#table4-4){ref-type="table"} was recorded.

[**Table 4-6**](#table4-6){ref-type="table"} summarizes the vascular grafts used for the infrainguinal arterial reconstruction. For example, the total number of vascular graft in the column of femoral-proximal popliteal artery bypass was 100 (98), which was higher than 87 (87), the number of actual applications in [**Table 4-2**](#table4-2){ref-type="table"}. This was because multiple graft materials could be selected when multiple procedures such as a bypass procedure and TEA can be performed simultaneously for arterial reconstruction in a lower limb. A composite bypass (prosthetic graft+vein) might be recorded into two grafts. When TEA without patch angioplasty was performed, "unused" was selected.

(4) Outcomes early (one month) after treatment
----------------------------------------------

[**Tables 5-1**](#table5-1){ref-type="table"}[](#table5-2){ref-type="table"}[](#table5-3){ref-type="table"}[](#table5-4){ref-type="table"}[](#table5-5){ref-type="table"}[](#table5-6){ref-type="table"}[](#table5-7){ref-type="table"} to [**5-8**](#table5-8){ref-type="table"} show the outcomes of early (one month) after treatment. At the time of summary count at the end of March 2019, follow-up data one month after treatment were obtained in 961 limbs (85%), including 940 limbs (94%) with ASO. Data were collected according to the severity of the local limb conditions (Rutherford classification) and treatment measures (EVT alone or surgical reconstruction with/without EVT). The mortality was 3.5% (3.6%) in the whole series, and 4.7% (4.7%) and 2.3% (2.4%) treated by EVT alone and by surgical reconstruction with/without EVT, respectively. The most common cause of death was cardiac disease and infection, both of which accounted for 24% (24%) of all deaths. Postoperative complications were cardiac disease in 2.1% (2.2%), cerebrovascular disease in 1.1% (1.1%), pneumonia in 1.6% (1.6%), and wound complication in 4.8% (4.5%). Complications at the puncture site were noted in 0.7% (0.7%) of the limbs treated by EVT alone.

###### Table 5 Outcomes early (one month) after treatment therapeutic measures: EVT (only EVT without surgical reconstruction), surgical reconstruction (surgical reconstruction with or without EVT) Table 5-1 Life prognosis/causes of death

  a\. Total                                                                                                                                                                                                                                                           
  ------------------------- -------------------- ---------------------- ----------------- ------------------------- -------------------- ---------------------------- ----------- -------------------- --------------------------- -------- --------- --- --- --- --- ---
  Local condition           Rutherford 4         178                    5                 0                         0                    0                            0           0                    0                           1        0         2   0   0   0   2
  Rutherford 5              609                  21                     1                 7                         0                    1                            0           0                    1                           0        2         1   1   6   2   
  Rutherford 6              140                  7                      0                 1                         0                    0                            0           0                    0                           4        0         0   1   0   1   
  Therapeutic measures      Non-reconstruction   38                     3                 0                         0                    0                            0           0                    0                           0        1         1   0   0   1   0
  EVT                       384                  19                     0                 4                         0                    0                            0           0                    1                           3        0         0   2   4   5   
  Surgical reconstruction   505                  11                     1                 4                         0                    1                            0           0                    1                           0        3         1   0   1   0   
  Total                     927                  33                     1                 8                         0                    1                            0           0                    2                           4        4         1   2   6   5   
  b\. ASO                                                                                                                                                                                                                                                             
                            Life prognosis       Causes of death                                                                                                                                                                                                      
  Alive                     Dead                 Intraoperative death   Cardiac disease   Cerebrovascular disease   Malignant neoplasm   Aortic aneurysm/dissection   Infection   Ischemic enteritis   Gastrointestinal bleeding   Others   Unknown                   
  Hemorrhage                Infarction           Unknown                Diseased limb     Others                                                                                                                                                                      
  Local condition           Rutherford 4         173                    5                 0                         0                    0                            0           0                    0                           1        0         2   0   0   0   2
  Rutherford 5              594                  21                     0                 7                         0                    1                            0           0                    1                           0        2         1   1   6   2   
  Rutherford 6              139                  7                      0                 1                         0                    0                            0           0                    0                           4        0         0   1   0   1   
  Therapeutic measures      Non-reconstruction   37                     3                 0                         0                    0                            0           0                    0                           0        1         1   0   0   1   0
  EVT                       382                  19                     0                 4                         0                    0                            0           0                    1                           3        0         0   2   4   5   
  Surgical reconstruction   487                  11                     1                 4                         0                    1                            0           0                    1                           0        3         1   0   1   0   
  Total                     906                  33                     1                 8                         0                    1                            0           0                    2                           4        4         1   2   6   5   

###### Table 5-2 Perioperative complications 1

  a\. Total                                                                                                                                                                                                                 
  ------------------------- --------------------- ---------------------------- ----------------------- -------------------- --------------------- --------------------- ----- ----- ----- ----- ----- ----- ----- ----- --- ---
  Local condition           Rutherford 4          168                          2                       0                    2                     171                   0     1     0     166   6     166   6     172   0   0
  Rutherford 5              606                   7                            2                       3                    611                   1                     4     2     612   6     583   35    608   8     2   
  Rutherford 6              138                   2                            2                       0                    140                   0                     0     2     139   3     138   4     141   1     0   
  Therapeutic measures      Non-reconstruction    13                           0                       0                    0                     13                    0     0     0     12    1     11    2     13    0   0
  EVT                       392                   9                            2                       0                    398                   1                     1     3     398   5     397   6     397   5     1   
  Surgical reconstruction   507                   2                            2                       5                    511                   0                     4     1     507   9     479   37    511   4     1   
  Total                     912                   11                           4                       5                    922                   1                     5     4     917   15    887   45    921   9     2   
  b\. ASO                                                                                                                                                                                                                   
                            Cardiac disease       Cerebrovascular disease      Pneumonia               Wound complication   Peripheral embolism                                                                             
  (−)                       Angina                Serious arrhysmia            Myocardial infarction   (−)                  TIA                   Cerebral infarction   (−)   (+)   (−)   (+)   (−)   (+)                   
  Functional loss (−)       Functional loss (+)   Minor (including blue toe)   Major                                                                                                                                        
  Local condition           Rutherford 4          163                          2                       0                    2                     166                   0     1     0     161   6     162   5     167   0   0
  Rutherford 5              592                   7                            2                       3                    597                   1                     4     2     598   6     572   32    594   8     2   
  Rutherford 6              137                   2                            2                       0                    139                   0                     0     2     138   3     137   4     140   1     0   
  Therapeutic measures      Non-reconstruction    13                           0                       0                    0                     13                    0     0     0     12    1     11    2     13    0   0
  EVT                       390                   9                            2                       0                    396                   1                     1     3     396   5     395   6     395   5     1   
  Surgical reconstruction   489                   2                            2                       5                    493                   0                     4     1     489   9     465   33    493   4     1   
  Total                     892                   11                           4                       5                    902                   1                     5     4     897   15    871   41    901   9     2   

TIA: transient ischemic attack

###### Table 5-3 Perioperative complications 2

  a\. Total                                                                                                                                                                                                                     
  ------------------------- -------------------- ------------------- --------------------- ------------------------------------- ------------------------------- ------- --------- ------ -------- ----- ----- ----- ----- ---- ---
  Local condition           Rutherford 4         172                 0                     0                                     0                               0       0         0      0        0     0     170   2     84   0
  Rutherford 5              604                  13                  1                     2                                     2                               9       11        0      2        0     613   5     319   6    
  Rutherford 6              139                  2                   1                     0                                     1                               1       2         0      0        0     141   1     83    0    
  Therapeutic measures      Non-reconstruction   12                  0                     1                                     0                               0       0         0      0        0     0     13    0     8    1
  EVT                       396                  6                   1                     1                                     2                               3       5         0      1        0     400   3     400   3    
  Surgical reconstruction   507                  9                   0                     1                                     1                               7       8         0      1        0     511   5     78    2    
  Total                     915                  15                  2                     2                                     3                               10      13        0      2        0     924   8     486   6    
  b\. ASO                                                                                                                                                                                                                       
                            Hemorrhage           Sites of bleeding   Outcome of bleeding   Complication due to contrast medium   Complication at puncture site                                                                  
  (−)                       (+)                  Unknown             Brain                 GI tract                              Others                          Cured   Uncured   Dead   Others   (−)   (+)   (−)   (+)        
  Local condition           Rutherford 4         167                 0                     0                                     0                               0       0         0      0        0     0     165   2     83   0
  Rutherford 5              590                  13                  1                     2                                     2                               9       11        0      2        0     599   5     317   6    
  Rutherford 6              138                  2                   1                     0                                     1                               1       2         0      0        0     140   1     83    0    
  Therapeutic measures      Non-reconstruction   12                  0                     1                                     0                               0       0         0      0        0     0     13    0     8    1
  EVT                       394                  6                   1                     1                                     2                               3       5         0      1        0     398   3     398   3    
  Surgical reconstruction   489                  9                   0                     1                                     1                               7       8         0      1        0     493   5     77    2    
  Total                     895                  15                  2                     2                                     3                               10      13        0      2        0     904   8     483   6    

GI: gastrointestinal

###### Table 5-4 Hemodynamics

  a\. Total                                                                                                                                                                          
  ------------------------- ------------------------------- ------------------------------- -------- ---------------- -------- ------ -------- ------ -------- ------- -------- ---- ----
  Local condition           Rutherford 4                    102                             0.83     99               104      36     36       81     0.90     75      120      14   36
  Rutherford 5              243                             0.89                            237      118              210      42.5   172      0.93   167      123     88       47   
  Rutherford 6              38                              0.90                            35       114              33       42     25       0.94   25       132     18       49   
  Therapeutic measures      Non-reconstruction              12                              0.815    9                127      6      49.5     7      0.86     2       114.5    1    66
  EVT                       176                             0.865                           173      114              133      41     136      0.91   133      120     68       43   
  Surgical reconstruction   195                             0.89                            189      112              140      43     135      0.94   132      126     51       50   
  Total                     383                             0.87                            371      113              279      42     278      0.92   267      123     120      47   
  b\. ASO                                                                                                                                                                            
                            Immediate after the treatment   One month after the treatment                                                                                            
  ABI                       Ankle pressure                  SPP                             ABI      Ankle pressure   SPP                                                            
  n                         Median                          n                               Median   n                Median   n      Median   n      Median   n       Median        
  Local condition           Rutherford 4                    100                             0.82     97               103      35     36       79     0.89     73      120      13   36
  Rutherford 5              239                             0.89                            233      118              208      42.5   166      0.92   162      123.5   88       47   
  Rutherford 6              38                              0.9                             35       114              33       42     25       0.94   25       132     18       49   
  Therapeutic measures      Non-reconstruction              12                              0.815    9                127      6      49.5     6      0.82     2       114.5    2    48
  EVT                       175                             0.86                            172      113.5            133      41     136      0.91   133      120     68       43   
  Surgical reconstruction   190                             0.89                            184      111.5            137      43     128      0.94   125      126     50       50   
  Total                     377                             0.87                            365      112              276      42     270      0.92   260      123.5   119      47   

ABI: ankle brachial (pressure) index, SPP: skin perfusion pressure

###### Table 5-5 Condition of the limbs

  a\. Total                                                                                                                                                                                                                                                                                                                   
  ------------------------- ---------------------------- ------------------------------- ---------------- ------------------------------------------------------------ ----------- -------- ---------- ----------- -------------- ------- --------- --------- ------------ ---------------------- --------------- ----- ----- ----
  Local condition           Rutherford 4                 159                             2                2                                                            1           0        0          3           159            13      4         113       49           13                     1               133   26    24
  Rutherford 5              546                          20                              21               2                                                            2           3        4          522         74             27      139       366       111          7                      312             155   163   
  Rutherford 6              120                          4                               1                0                                                            0           0        4          101         22             8       14        80        36           1                      42              33    72    
  Therapeutic measures      Non-reconstruction           0                               0                0                                                            0           0        0          0           14             3       2         8         6            5                      0               19    6     16
  EVT                       349                          15                              12               1                                                            0           1        7          306         72             21      100       202       90           7                      196             75    132   
  Surgical reconstruction   476                          11                              12               2                                                            2           2        4          462         34             16      158       287       65           2                      272             133   111   
  Total                     825                          26                              24               3                                                            2           3        11         782         109            39      266       495       160          9                      487             214   259   
  b\. ASO                                                                                                                                                                                                                                                                                                                     
                            Bypass graft/EVT condition   Clinical symptoms of the limb   Ischemic wound   Ambulatory function at discharge (Taylor's classification)                                                                                                                                                          
  Good                      Stenosis                     Occlusion                       Deterioration    Anastomosis disruption (aneurysm)                            Infection   Others   Improved   No change   Deteriorated   Cured   Uncured   Unknown   Ambulatory   Ambulatory/homebound   Nonambulatory               
  Improved                  Unchanged/deteriorated                                                                                                                                                                                                                                                                            
  Local condition           Rutherford 4                 155                             2                2                                                            1           0        0          2           155            12      4         109       49           13                     0               128   26    24
  Rutherford 5              535                          20                              18               2                                                            2           3        4          511         70             27      138       357       106          7                      302             153   160   
  Rutherford 6              119                          4                               1                0                                                            0           0        4          100         22             8       13        80        36           1                      42              32    72    
  Therapeutic measures      Non-reconstruction           0                               0                0                                                            0           0        0          0           14             2       2         8         6            4                      0               18    6     16
  EVT                       347                          15                              12               1                                                            0           1        7          304         72             21      99        202       89           7                      195             74    132   
  Surgical reconstruction   462                          11                              9                2                                                            2           2        3          448         30             16      153       278       62           1                      259             131   108   
  Total                     809                          26                              21               3                                                            2           3        10         766         104            39      260       486       155          8                      472             211   256   

###### Table 5-6 Revision of treatment

  a\. Total                                                                                                                                                                                                                                                                                                                                                
  --------------------------- -------------------------------------------------------------- ---------------------------------------------- ----------------------------------------------- ------------------ -------- ----- ------------------------------ -------------- ----- ----------- ------------- --------------- -------- ----- ----- ----- --- ---
  Local condition             Rutherford 4                                                   3                                              5                                               166                0        3     2                              167            1     0           1             0               0        1     1     174   7   1
  Rutherford 5                27                                                             25                                             580                                             1                  28       3     592                            5              0     3           5             3               2        2     603   20    1   
  Rutherford 6                6                                                              3                                              123                                             0                  5        0     123                            0              0     1           2             2               0        0     117   16    0   
  Therapeutic measures        Non-reconstruction                                             0                                              0                                               0                  0        0     0                              0              0     0           0             0               0        0     0     25    3   0
  EVT                         16                                                             22                                             377                                             0                  18       4     382                            1              0     5           6             2               2        1     372   27    0   
  Surgical reconstruction     17                                                             14                                             492                                             1                  18       1     500                            5              0     0           1             3               1        2     497   13    2   
  Total                       33                                                             36                                             869                                             1                  36       5     882                            6              0     5           7             5               3        3     894   43    2   
  b\. ASO                                                                                                                                                                                                                                                                                                                                                  
                              Revision for those excluding good bypass graft/EVT condition   Minor reintervention (revision for stenosis)   Major reintervention (revision for occlusion)   Major amputation                                                                                                                                               
  (+)                         (−)                                                            (−)                                            Patch plasty                                    EVT                Others   (−)   Thrombectomy (±patch plasty)   Thrombolysis   EVT   Re-bypass   Jump bypass   Interposition   Others   (−)   (+)             
  Due to preoperative wound   Due to new wound                                                                                                                                                                                                                                                                                                             
  Local condition             Rutherford 4                                                   2                                              5                                               161                0        3     2                              162            1     0           1             0               0        1     1     169   7   1
  Rutherford 5                26                                                             23                                             566                                             1                  28       3     580                            4              0     3           5             2               2        2     589   19    1   
  Rutherford 6                6                                                              3                                              122                                             0                  5        0     122                            0              0     1           2             2               0        0     116   16    0   
  Therapeutic measures        Non-reconstruction                                             0                                              0                                               0                  0        0     0                              0              0     0           0             0               0        0     0     24    3   0
  EVT                         16                                                             22                                             375                                             0                  18       4     380                            1              0     5           6             2               2        1     370   27    0   
  Surgical reconstruction     15                                                             12                                             474                                             1                  18       1     484                            4              0     0           1             2               1        2     480   12    2   
  Total                       31                                                             34                                             849                                             1                  36       5     864                            5              0     5           7             4               3        3     874   42    2   

###### Table 5-7 Condition of contralateral limbs

  a\. Total                                                                                                                                                                                                                                                                                                             
  ------------------------- -------------------------------------- ---------------------------------- ---------------- ------------------------- -------------------- ----- ----------------- ------------------ ------------------ ---------------------- ---------------------------- -------- ---- ---- --- ---- --- ---
  Local condition           Rutherford 4                           55                                 65               16                        6                    2     0                 39                 11                 91                     0                            23       14   1    4   0    1   0
  Rutherford 5              163                                    235                                32               8                         48                   6     138               47                 299                1                      68                           67       8    17   0   8    1   
  Rutherford 6              32                                     48                                 5                0                         11                   8     43                9                  73                 0                      20                           11       5    11   0   3    0   
  Therapeutic measures      Non-reconstruction                     14                                 13               1                         1                    3     2                 7                  2                  16                     0                            2        4    1    1   0    1   0
  EVT                       91                                     159                                19               3                         27                   9     95                31                 206                0                      76                           18       5    20   0   6    0   
  Surgical reconstruction   145                                    176                                33               10                        31                   3     118               34                 241                1                      33                           69       8    11   0   5    1   
  Total                     250                                    348                                53               14                        61                   14    220               67                 463                1                      111                          91       14   32   0   12   1   
  b\. ASO                                                                                                                                                                                                                                                                                                               
                            Contralateral limb occlusive lesions   Treatment for contralateral limb                                                                                                                                                                                                                     
  (−)                       (+)                                    Unnecessary                        (+)                                                                                                                                                                                                               
  Asymptomatic              Intermittent claudication              CLI                                Post-treatment   Pharmacological therapy   Angiogenic therapy   EVT   Surgical bypass   Minor amputation   Major amputation   Lumber sympathectomy   Necessary but no treatment   Others                          
  R4                        R5                                     R6                                                                                                                                                                                                                                                   
  Local condition           Rutherford 4                           54                                 62               15                        6                    2     0                 39                 11                 87                     0                            23       14   1    4   0    1   0
  Rutherford 5              153                                    234                                32               8                         46                   6     136               47                 296                1                      68                           65       8    16   0   8    1   
  Rutherford 6              32                                     47                                 5                0                         11                   8     43                9                  72                 0                      20                           11       5    11   0   3    0   
  Therapeutic measures      Non-reconstruction                     13                                 13               1                         1                    3     2                 7                  2                  16                     0                            2        4    1    1   0    1   0
  EVT                       91                                     159                                19               3                         26                   9     94                31                 205                0                      76                           18       5    19   0   6    0   
  Surgical reconstruction   135                                    171                                32               10                        30                   3     117               34                 234                1                      33                           68       8    11   0   5    1   
  Total                     239                                    343                                52               14                        59                   14    218               67                 455                1                      111                          90       14   31   0   12   1   

CLI: critical limb ischemia

###### Table 5-8 Malignant neoplasm

  a\. Total                                                                                                                                                                                                                                      
  ------------------------- ------------------------------------ --------------------------------------------- --------------- ----------- ------ --------- ------------------------ ------- -------- -------- --------- ---------- -------- --- ---
  Local condition           Rutherford 4                         181                                           2               0           0      0         0                        0       1        1        0         0          0        0   0
  Rutherford 5              625                                  2                                             3               0           0      0         2                        0       0        0        0         0          0        0   
  Rutherford 6              145                                  1                                             1               0           0      0         1                        0       0        0        0         0          0        0   
  Therapeutic measures      Non-reconstruction                   40                                            0               1           0      0         0                        0       1        1        0         0          0        0   0
  EVT                       397                                  4                                             2               0           0      0         2                        0       0        0        0         0          0        0   
  Surgical reconstruction   514                                  1                                             1               0           0      0         1                        0       0        0        0         0          0        0   
  Total                     951                                  5                                             4               0           0      0         3                        1       1        0        0         0          0        0   
  b\. ASO                                                                                                                                                                                                                                        
                            Newly diagnosed malignant neoplasm   Sites of newly diagnosed malignant neoplasm                                                                                                                                     
  (−)                       (+)                                  Unknown                                       Head and neck   Esophagus   Lung   Stomach   Hepatobiliary pancreas   Colon   Breast   Uterus   Ovarium   Prostate   Others       
  Local condition           Rutherford 4                         176                                           2               0           0      0         0                        0       1        1        0         0          0        0   0
  Rutherford 5              610                                  2                                             3               0           0      0         2                        0       0        0        0         0          0        0   
  Rutherford 6              144                                  1                                             1               0           0      0         1                        0       0        0        0         0          0        0   
  Therapeutic measures      Non-reconstruction                   39                                            0               1           0      0         0                        0       1        1        0         0          0        0   0
  EVT                       395                                  4                                             2               0           0      0         2                        0       0        0        0         0          0        0   
  Surgical reconstruction   496                                  1                                             1               0           0      0         1                        0       0        0        0         0          0        0   
  Total                     930                                  5                                             4               0           0      0         3                        1       1        0        0         0          0        0   

The median ABI and SPP of the measured limbs, immediately after treatment and one month after treatment, were 0.87 (0.87) and 0.92 (0.92) and 42 (42) mmHg and 47 (47) mmHg, respectively. Stenosis, occlusion, infection, or other trouble occurred after revascularization by EVT alone in 9.4% (9.4%) and by surgical reconstruction with/without EVT in 6.5% (5.9%). Secondary major amputation rate was 6.8% (6.8%) in EVT alone and 2.9% (2.8%) in surgical reconstruction with/without EVT. When ambulatory function at discharge was compared to that before surgery, the rate of patients with ambulatory changed from 58% (58%) to 50% (50%), ambulatory/homebound from 22% (22%) to 22% (22%), and non-ambulatory from 19% (20%) to 27% (27%).

The problems, comments, and considerations on these spreadsheets are described below. The number of "bypass graft/EVT condition," "clinical limb symptoms," "ischemic wound," and "ambulatory function at discharge" did not match ([**Table 5-5**](#table5-5){ref-type="table"}). The total number of "ambulatory function at discharge" was 960 (939), which was equal to the number of life prognoses after exclusion of one intraoperative death ([**Table 5-1**](#table5-1){ref-type="table"}), indicating no "unused." The number of "bypass graft/EVT condition" was not equal to the number of "ambulatory function at discharge" because the objectives of "bypass graft/EVT condition" were limbs of survivors with arterial reconstruction and because more than one condition could be selected. The number of "clinical symptoms of limb" and "ischemic wound" were not identical. They must be identical because their objectives were survivor without major amputations. This is speculated to be due to the presence of "unused." The discrepancy in the total number of "life prognosis," "clinical limb symptom" and "amputation" is due to the difference of condition for aggregation of data. In [**Table 5-3**](#table5-3){ref-type="table"}, the registration of complication at puncture site in non-reconstruction and surgical reconstruction seems to be odd. The registration of complication at puncture site was required in limbs where PTA/STENT was selected in the revascularization method. Since multiple treatment methods can be selected, complications at the puncture site was registered in non-reconstruction and surgical reconstruction.

The number of limbs of survivors with EVT was 384 (382 limbs) ([**Table 5-1**](#table5-1){ref-type="table"}), which was 15 (15) limbs less than the sum of the number in the column of minor reintervention or major reintervention in the row of limbs with EVT; 399 limbs (397 limbs) ([**Table 5-6**](#table5-6){ref-type="table"}). The number of limbs of survivors with surgical reconstruction was 505 (487 limbs) ([**Table 5-1**](#table5-1){ref-type="table"}), which was 7 (7) limbs less than the sum of the number in the column of minor reintervention or major reintervention in the row of limbs with surgical reconstruction; 512 limbs (494 limbs) ([**Table 5-6**](#table5-6){ref-type="table"}). This is speculated to be due to death after reintervention. In [**Table 5-5**](#table5-5){ref-type="table"}, the number of "clinical symptoms of limb and "ischemic wound" does not match, which was obtained regardless accurate aggregation of input data and the reason is unknown. In [**Table 5-6**](#table5-6){ref-type="table"}, the objective for input of "revision for those excluding good bypass graft/EVT condition" is limb registered in stenosis, occlusion, deterioration, anastomosis disruption (aneurysm), infection, others of "bypass graft/EVT condition." The total number of "the contralateral limb occlusive lesions" in [**Table 5-7**](#table5-7){ref-type="table"} is equal to that of "life prognosis" in [**Table 5-1**](#table5-1){ref-type="table"}. The information of contralateral limb at death was registered in a dead case. The sum of the number of "treatment for contralateral limb" is less than that of "the contralateral limb occlusive lesions" because the objectives of "treatment for contralateral limb" excluded the limbs of (-) in "the contralateral limb occlusive lesions." Since multiple registration was possible, the sum of the number of "treatment for contralateral limb" was more than that of (-) in "the contralateral limb occlusive lesions." When a patient died within one month, the information of "newly diagnosed malignant neoplasm" at death was registered in [**Table 5-8**](#table5-8){ref-type="table"}.

In addition to the above, there were some parts where the total number does not match in [**Tables 5-1**](#table5-1){ref-type="table"} to [**5-8**](#table5-8){ref-type="table"}. It might be because several items had multiple choices or missing values.

4. Conclusion
=============

Vascular surgeons' contribution in participating facilities registered a sufficient amount of detailed data during busy clinical practice, which has been gradually clarifying the current status of CLI treatment in Japan. Data on CLI in 2017 were clarified, after annual data in 2013--2016. The JCLIMB Committee is planning to continue publishing an annual report in the future. In 2017, the new concept, "chronic limb threatening ischemia," was proposed instead of CLI^[@R12])^ and a new clinical guideline, the Global Vascular Guideline, was published instead of TASC in 2019.^[@R13])^ The JCLIMB Committee ought to revise the survey items according to the Global Vascular Guideline and a new registration form, which can be used in 2021, is being prepared.

The JCLIMB Committee expects these study results will be fed back to clinical situations to help develop medical care for CLI and clinical studies using these data are ongoing. Facilities can participate in JCLIMB at any time by contacting the JSVS secretariat for details.

In the future, JCLIMB is designed to be extended to a system where physicians in departments other than vascular surgery will be able to register, track, and analyze CLTI, aiming at establishing a nationwide CLTI database in Japan.

5. Participant Facilities (84 Facilities in the Order of the Japanese Syllabary by Prefecture, Corporate Names are Omitted as a Rule)
=====================================================================================================================================

Department of Vascular Surgery, Asahikawa Medical University Hospital

Department of Cardiovascular Surgery, National Hospital Organization Obihiro Hospital

Department of Cardiovascular Surgery, Steel Memorial Muroran Hospital

Department of Cardiovascular Surgery, Nayoro City General Hospital

Department of Cardiovascular Surgery, Hirosaki University Hospital

Department of Surgery, Iwate Prefectural Iwai Hospital

Department of Surgery, Iwate Prefectural Isawa Hospital

Department of Surgery, Iwate Prefectural Chubu Hospital

Department of Vascular Surgery, Morioka Yuai Hospital

Department of Surgery, Karita General Hospital

Department of Surgery, JR Sendai Hospital

Department of Cardiovascular Surgery, Sendai City Hospital

Department of Transplantation, Reconstruction and Endoscopic Surgery, Tohoku University Hospital

Department of Cardiovascular Surgery, Saiseikai Yamagata Saisei Hospital

Department of Cardiovascular Surgery, Southern TOHOKU General Hospital

Department of Vascular and Endovascular Surgery, Ibaraki Prefectural Central Hospital

Department of Cardiac and Vascular Surgery, Dokkyo Medical University Nikko Medical Center

Department of Cardiac and Vascular Surgery, Dokkyo Medical University Hospital

Department of Vascular Surgery, Saiseikai Kawaguchi General Hospital

Department of Vascular Surgery, Saitama Medical Center, Saitama Medical University

Department of Cardiovascular Surgery, Saitama Medical Center, Jichi Medical University

Department of Cardiovascular Surgery, Jichi Medical University

Department of Cardiovascular Surgery, Tokorozawa Meisei Hospital

Department of Surgery, Saitama City Hospital

Department of Cardiac and Vascular Surgery, National Defense Medical College Hospital

Department of Cardiovascular Surgery, Shimada General Hospital

Department of Cardiovascular Surgery, Chiba Cerebral and Cardiovascular Center

Department of Cardiovascular Surgery, Itabashi Chuo Medical Center

Department of Cardiovascular Surgery, IMS Tokyo Katsushika General Hospital

Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Okubo Hospital

Department of Cardiovascular Surgery, Kyorin University

Department of Surgery, Keio University School of Medicine

Department of Vascular Surgery, International University of Health and Welfare, Mita Hospital

Department of Vascular Surgery, Tokyo Medical and Dental University

Department of Cardiovascular Surgery, Tokyo Medical University Hachioji Medical Center

Department of Cardiovascular Surgery, Tokyo Medical University Hospital

Department of Vascular Surgery, The Jikei University Kashiwa Hospital

Department of Vascular Surgery, The Jikei University Hospital

Department of Cardiovascular Surgery, Tokyo Women's Medical University Medical Center East

Department of Vascular Surgery, The University of Tokyo Hospital

Department of Cardiovascular Surgery, Tokyo Rinkai Hospital

Department of Vascular Surgery, Nihon University Itabashi Hospital

Department of Surgery, Shonankamakura General Hospital

Department of Vascular Surgery, Kawasaki Municipal Hospital
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